The Trendlines Group is pleased to announce investments in Arcuro Medical, FruitSpec, ProArc Medical and Phytolon.
Trendlines Medical Shanghai partners with Chinese medical companies, governmental programs, and entrepreneurs to develop novel medical technologies for the Chinese and global markets.
Trendlines Labs Singapore will invent and develop novel medical technologies, innovating and creating value for Trendlines’ portfolio companies and strategic partners
Barak Singer, CEO, Trendlines Incubators Israel was interviewed by Chiportal on investment during the COVID-19 crisis.
Trendlines Agrifood Innovation Centre one of fourteen new partners named by Enterprise Singapore to nurture start-ups
The Trendlines Group is pleased to share the following information with the wider public on resources which we collated to assist the Group’s companies in this challenging period. We’ve compiled information regarding funds, grants and other resourceful information for companies in the medtech and agrifood tech industries, as well as others.
The Trendlines Group announced the 100% acquisition of portfolio company ApiFix, a company focused on non-fusion treatment of progressive adolescent idiopathic scoliosis, by OrthoPediatrics
It’s not “business as usual,” it’s business unusual.
Featured in The Business Times and Deal Street Asia
Innovative interdisciplinary approach will lead to development of pesticides with new modes of action for crop protection